The Kidney Awareness Registry and Education (KARE) study: Protocol of a randomized controlled trial to enhance provider and patient engagement with chronic kidney disease

BMC Nephrology

Volumn 16, Issue 1, 2015, Pages

  Tuot, Delphine S ^a,c   Velasquez, Alexandra ^a   McCulloch, Charles E ^b   Banerjee, Tanushree ^a,c   Zhu, Yunnuo ^a   Hsu, Chi Yuan ^a   Handley, Margaret ^a,b   Schillinger, Dean ^b,c   Powe, Neil R ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Chronic kidney disease; CKD awareness; Health coaching; Self management

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; CLINICAL PROTOCOL; HEALTH STATUS; HUMAN; LOWEST INCOME GROUP; MEDICAL INFORMATICS; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT EDUCATION; POINT OF CARE SYSTEM; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; SELF CARE; SYSTOLIC BLOOD PRESSURE; TELEPHONE; ASIAN AMERICAN; ATTITUDE TO HEALTH; BLOOD PRESSURE; CALIFORNIA; CONTROLLED STUDY; CULTURAL COMPETENCE; DOCTOR PATIENT RELATION; HEALTH BEHAVIOR; HEALTH LITERACY; HISPANIC; INTERPERSONAL COMMUNICATION; LANGUAGE; METHODOLOGY; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; PROTOCOL COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RENAL INSUFFICIENCY, CHRONIC; STANDARDS; VULNERABLE POPULATION;

ASIAN AMERICANS; BLOOD PRESSURE; COMMUNICATION; CULTURAL COMPETENCY; GUIDELINE ADHERENCE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH LITERACY; HISPANIC AMERICANS; HUMANS; LANGUAGE; MEDICAL INFORMATICS; PATIENT CARE TEAM; PATIENT EDUCATION AS TOPIC; PHYSICIAN-PATIENT RELATIONS; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; REGISTRIES; RENAL INSUFFICIENCY, CHRONIC; RESEARCH DESIGN; SAN FRANCISCO; SELF CARE; VULNERABLE POPULATIONS;

EID: 84944691138     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/s12882-015-0168-4     Document Type: Article

References (48)

1. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro 3rd AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-12.
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-305.
3. Merkin SS, Roux AV, Coresh J, Fried LF, Jackson SA, Powe NR. Individual and neighborhood socioeconomic status and progressive chronic kidney disease in an elderly population: the cardiovascular health study. Soc Sci Med. 2007;65(4):809-21.
4. McClellan WM, Newsome BB, McClure LA, Howard G, Volkova N, Audhya P, et al. Poverty and racial disparities in kidney disease: the REGARDS study. Am J Nephrol. 2010;32(1):38-46.
5. Tarver-Carr ME, Powe NR, Eberhardt MS, LaVeist TA, Kington RS, Coresh J, et al. Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol. 2002;13(9):2363-70.
6. Hall YN, Choi AI, Chertow GM, Bindman AB. Chronic kidney disease in the urban poor. Clin J Am Soc Nephrol. 2010;5(5):828-35.
7. Hall YN, Rodriguez RA, Boyko EJ, Chertow GM, O'Hare AM. Characteristics of uninsured Americans with chronic kidney disease. J Gen Intern Med. 2009;24(8):917-22.
8. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998, 317(7160):703-713.
9. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861-9.
10. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345(12):851-60.
11. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet 1997, 349(9069):1857-1863.
12. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993, 329(14):977-986.
13. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998, 352(9131):837-853.
14. KDIGO. Clinical practice guideline for the evaluation and management of chronic kidney disease. Summary of recommendation statements. Kidney Int Suppl 2013. 2012;3(1):5-14.
15. Plantinga LC, Tuot DS, Powe NR. Awareness of chronic kidney disease among patients and providers. Adv Chronic Kidney Dis. 2010;17(3):225-36.
16. Tuot D, Plantinga L, Judd S, Muntner P, Hsu C, Warnock DG, et al.. Health behaviors, risk factor control and awareness of chronic kidney disease. Am J Nephrol. In press. 2013.
17. Tuot DS, Plantinga LC, Hsu CY, Jordan R, Burrows NR, Hedgeman E, et al. Chronic kidney disease awareness among individuals with clinical markers of kidney dysfunction. Clin J Am Soc Nephrol. 2011;6(8):1838-44.
18. Tahir MA, Dmitrieva O, de Lusignan S, van Vlymen J, Chan T, Golmohamad R, et al. Confidence and quality in managing CKD compared with other cardiovascular diseases and diabetes mellitus: a linked study of questionnaire and routine primary care data. BMC Fam Pract. 2011;12:83.
19. Costantini L, Beanlands H, McCay E, Cattran D, Hladunewich M, Francis D. The self-management experience of people with mild to moderate chronic kidney disease. Nephrol Nurs J. 2008;35(2):147-55. quiz 156.
20. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;288(19):2469-75.
21. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff (Millwood). 2001;20(6):64-78.
22. American College of Physicians. The Patient-Centered Medical Home Neighbod: The Interface of the Patient Centered Medical Home With Specialty/Subspecialty Practices. Philadelphia, PA: American College of Physicians; 2010.
23. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333(18):1190-5.
24. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA. 2002;288(15):1909-14.
25. Halladay JR, Dewalt DA, Wise A, Qaqish B, Reiter K, Lee SY, et al. More extensive implementation of the chronic care model is associated with better lipid control in diabetes. J Am Board Fam Med. 2014;27(1):34-41.
26. Volkova N, McClellan W, Klein M, Flanders D, Kleinbaum D, Soucie JM, et al. Neighborhood poverty and racial differences in ESRD incidence. J Am Soc Nephrol. 2008;19(2):356-64.
27. Schillinger D. Literacy and health communication: reversing the 'inverse care law'. Am J Bioeth. 2007;7(11):15-8. discussion W11-12.
28. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130(6):461-70.
29. McBride D, Dohan D, Handley MA, Powe NR, Tuot DS. Developing a CKD registry in primary care: provider attitudes and input. Am J Kidney Dis. 2013.
30. Painter JE, Borba CP, Hynes M, Mays D, Glanz K. The use of theory in health behavior research from 2000 to 2005: a systematic review. Ann Behav Med. 2008;35(3):358-62.
31. Glanz K, Rimer BK, Viswanath K. Health behavior and health education: theory, research, and practice. 4th ed. San Francisco, CA: Jossey-Bass; 2008.
32. Schillinger D, Handley M, Wang F, Hammer H. Effects of self-management support on structure, process, and outcomes among vulnerable patients with diabetes: a three-arm practical clinical trial. Diabetes Care. 2009;32(4):559-66.
33. Tuot DS, Davis E, Velasquez A, Banerjee T, Powe NR. Assessment of printed patient-educational materials for chronic kidney disease. Am J Nephrol. 2013;38(3):184-94.
34. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the american heart association council on high blood pressure research. Circulation. 2005;111(5):697-716.
35. Boulware LE, Troll MU, Jaar BG, Myers DI, Powe NR. Identification and referral of patients with progressive CKD: a national study. Am J Kidney Dis. 2006;48(2):192-204.
36. Campbell C, Lockyer J, Laidlaw T, Macleod H. Assessment of a matched-pair instrument to examine doctor-patient communication skills in practising doctors. Med Educ. 2007;41(2):123-9.
37. Ware Jr J, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-33.
38. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74.
39. Lorig K, Stewart AF, Ritter P, Gonzalez V, Laurent D, Lynch J. Outcome Measures for Health Education and Other Health Care Intervensions. Thousand Oaks, CA: Sage Publications; 1996.
40. Behavioral Risk Factor Surveillance System Survey Questionnaire. In. Atlanta, Ceorgia: The U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC); 2011.
41. Glasgow RE, Nelson CC, Strycker LA, King DK. Using RE-AIM metrics to evaluate diabetes self-management support interventions. Am J Prev Med. 2006;30(1):67-73.
42. Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009;169(19):1748-55.
43. Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713-35.
44. KDIGO. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2012;2013:3(1).
45. Tuot DS, Plantinga LC, Hsu CY, Powe NR. Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes? Am J Nephrol. 2012;35(2):191-7.
46. Tuot DS, Powe NR. Chronic kidney disease in primary care: an opportunity for generalists. J Gen Intern Med. 2011;26(4):356-8.
47. Tuot DS, Grubbs V. Chronic kidney disease care in the US safety Net. Adv Chronic Kidney Dis. 2015;22(1):66-73.
48. Willard-Grace R, Chen EH, Hessler D, DeVore D, Prado C, Bodenheimer T, et al. Health coaching by medical assistants to improve control of diabetes, hypertension, and hyperlipidemia in low-income patients: a randomized controlled trial. Ann Fam Med. 2015;13(2):130-8.